Standout Papers
Citation Impact
Citing Papers
Real-Time Prognosis for Metastatic Thyroid Carcinoma Based on 2-[18F]Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography Scanning
2006
Protein characterization of Saccharomyces cerevisiae RNA polymerase II after in vivo cross-linking
2007 StandoutNobel
Lipid Rafts As a Membrane-Organizing Principle
2009 StandoutScience
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
2010 StandoutNobel
Human somatotropin 53. Synthesis and biological activity of the amino terminal fifty-four residue fragment.
1977
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Biological effects of human growth hormone in rat adipocyte precursor cells and newly differentiated adipocytes in primary culture
1996
Gene expression profiling predicts clinical outcome of breast cancer
2002 StandoutNature
rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review
2005
Analysis of gene expression during adipogenesis in 3T3‐F442A preadipocytes: Insulin and dexamethasone control
1990
Guidelines for radioiodine therapy of differentiated thyroid cancer
2008
Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome?
2010
Cellular and Molecular Aspects of Adipose Tissue Development
1992
Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
2013
Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer
2001 Standout
Role of metastasectomy in the management of thyroid carcinoma: The NIH experience
2002
Maximal safe dose of I-131 after failure of standard fixed dose therapy in patients with differentiated thyroid carcinoma
2008
Smad-dependent and Smad-independent pathways in TGF-β family signalling
2003 StandoutNature
Dosimetry-guided high-activity 131I therapy in patients with advanced differentiated thyroid carcinoma: initial experience
2009
Clinical applications of 124I-PET/CT in patients with differentiated thyroid cancer
2011
Follow up Approaches in Thyroid Cancer: A Risk Adapted Paradigm
2008
Solid phase peptide synthesis utilizing 9‐fluorenylmethoxycarbonyl amino acids
1990 Standout
Radioiodine Treatment with 30 mCi after Recombinant Human Thyrotropin Stimulation in Thyroid Cancer: Effectiveness for Postsurgical Remnants Ablation and Possible Role of Iodine Content inl -Thyroxine in the Outcome of Ablation
2003
Complete Adipose Differentiation of 3T3 LI Cells in a Chemically Defined Medium: Comparison to Serum-Containing Culture Conditions*
1990
Management of paediatric thyroid carcinoma: recent experience with recombinant human thyroid stimulating hormone in preparation for radioiodine therapy
2006
AU-Rich-Element-Mediated Upregulation of Translation by FXR1 and Argonaute 2
2007
Dosimetry and thyroid cancer: the individual dosage of radioiodine
2010
Proton conductance caused by long-chain fatty acids in phospholipid bilayer membranes
1988
Transmembrane Pickets Connect Cyto- and Pericellular Skeletons Forming Barriers to Receptor Engagement
2018 StandoutNobel
Thirteen decades of peptide synthesis: key developments in solid phase peptide synthesis and amide bond formation utilized in peptide ligation
2017
Cardiotonic steroids on the road to anti-cancer therapy
2007
Radioiodine in the Treatment of Thyroid Cancer
2007
Positron emission tomography in thyroid cancer management
2002
The role of growth hormone/insulin-like growth factors in adipocyte differentiation
1995
Recurrence detection in differentiated thyroid cancer patients with elevated serum level of antithyroglobulin antibody: special emphasis on using 18F‐FDG PET/CT
2009
The SNMMI Practice Guideline for Therapy of Thyroid Disease with 131I 3.0
2012
Cyclins and breast cancer
1998
Compassionate Use of Recombinant Human Thyrotropin to Facilitate Radioiodine Therapy: Case Report and Review of Literature
2000
I-131 Activities as High as Safely Administrable (AHASA) for the Treatment of Children and Adolescents with Advanced Differentiated Thyroid Cancer
2011
EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy
2008
Dosimetrically Determined Doses of Radioiodine for the Treatment of Metastatic Thyroid Carcinoma
2002
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
Utility of the Radioiodine Whole-Body Retention at 48 Hours for Modifying Empiric Activity of 131-Iodine for the Treatment of Metastatic Well-Differentiated Thyroid Carcinoma
2009
The Benefits and Risks of I-131 Therapy in Patients with Well-Differentiated Thyroid Cancer
2009
Quality of Life and Effectiveness Comparisons of Thyroxine Withdrawal, Triiodothyronine Withdrawal, and Recombinant Thyroid-Stimulating Hormone Administration for Low-Dose Radioiodine Remnant Ablation of Differentiated Thyroid Carcinoma
2010
Postradioiodine Treatment Whole-Body Scan in the Era of 18-Fluorodeoxyglucose Positron Emission Tomography for Differentiated Thyroid Carcinoma with Elevated Serum Thyroglobulin Levels
2012
Recombinant Human Thyroid Stimulating Hormone–Assisted Radioactive Iodine Remnant Ablation in Thyroid Cancer Patients at Intermediate to High Risk of Recurrence
2012
Protein Denaturation
1968 Standout
Roles of Autocrine TGF-β Receptor and Smad Signaling in Adipocyte Differentiation
2000
Influence of sodium on the alpha 2-adrenergic receptor system of human platelets. Role for intraplatelet sodium in receptor binding.
1983
Insulin-Receptor Interaction in the Obese-Hyperglycemic Mouse
1973
PAROTIN: A SALIVARY GLAND HORMONE
1960
Membrane proteins: Amino acid sequence and membrane penetration
1974
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
2008 StandoutNobel
Localized deposition of chitin on the yeast cell surface in response to mating pheromone
1979 StandoutNobel
Adenylate cyclase activity in lymphocyte subcellular fractions. Characterization of a nuclear adenylate cyclase
1977
[18F]-2-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography Localizes Residual Thyroid Cancer in Patients with Negative Diagnostic 131I Whole Body Scans and Elevated Serum Thyroglobulin Levels
1999
Receptor-mediated transcellular transport of immunoglobulin: synthesis of secretory component as multiple and larger transmembrane forms.
1980 StandoutNobel
Interleaflet clear space is reduced in the membrane of COP I and COP II-coated buds/vesicles.
1996 StandoutNobel
Dosimetry-guided radioactive iodine treatment in patients with metastatic differentiated thyroid cancer: largest safe dose using a risk-adapted approach.
2003
Adipose conversion of 3T3-L1 cells in a serum-free culture system depends on epidermal growth factor, insulin-like growth factor I, corticosterone, and cyclic AMP.
1990
Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software.
2004
Functional rafts in cell membranes
1997 StandoutNature
Selective active site inhibitors of human lactate dehydrogenases A4, B4, and C411Abbreviations: LDH, lactate dehydrogenase; and LDH-A4, -B4, and -C4, human lactate dehydrogenases A4, B4, and C4.
2001
Lithium as a Potential Adjuvant to 131I Therapy of Metastatic, Well Differentiated Thyroid Carcinoma1
1999
Prognostic Value of [18F]Fluorodeoxyglucose Positron Emission Tomographic Scanning in Patients with Thyroid Cancer
2000
Adenosine analogs inhibit adipocyte adenylate cyclase by a GTP-dependent process: basis for actions of adenosine and methylxanthines on cyclic AMP production and lipolysis.
1978 StandoutNobel
The Fluid Mosaic Model of the Structure of Cell Membranes
1972 StandoutScience
Membrane growth can generate a transmembrane pH gradient in fatty acid vesicles
2004 StandoutNobel
Concept of internal structural controls for evaluation of inactive synthetic peptide analogs: synthesis of [Orn13,14]apamin and its guanidination to an apamin derivative with full neurotoxic activity.
1977 StandoutNobel
The role of hormone receptors and GTP-regulatory proteins in membrane transduction
1980 StandoutNatureNobel
STUDIES OF THE AROMATIC CIRCULAR DICHROISM OF STAPHYLOCOCCAL NUCLEASE
1969 StandoutNobel
Clustering and endocytosis of membrane receptors can be induced in mature erythrocytes of neonatal but not adult humans.
1976 StandoutNobel
Multistep Solid-State Organic Synthesis of Carbamate-Linked Covalent Organic Frameworks
2019 StandoutNobel
Molecular Biology of Cellular Membranes with Applications to Immunology
1974
Regulation of Insulin-Like Growth Factor-I Ribonucleic Acid Expression, Polypeptide Secretion, and Binding Protein Activity by Growth Hormone in Porcine Preadipocyte Cultures*
1990
The cAMP-binding domains of the regulatory subunit of cAMP-dependent protein kinase and the catabolite gene activator protein are homologous.
1982 StandoutNobel
A Comparison of 1850 (50 mCi) and 3700 MBq (100 mCi) 131-Iodine Administered Doses for Recombinant Thyrotropin-Stimulated Postoperative Thyroid Remnant Ablation in Differentiated Thyroid Cancer
2007
The protein encoded by the transforming gene of avian sarcoma virus (pp60src) and a homologous protein in normal cells (pp60proto-src) are associated with the plasma membrane.
1980 StandoutNobel
Patients With Differentiated Thyroid Cancer Who Underwent Radioiodine Thyroid Remnant Ablation With Low-Activity 131I After Either Recombinant Human TSH or Thyroid Hormone Therapy Withdrawal Showed the Same Outcome After a 10-Year Follow-up
2013
Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancer
2010
Cyclic AMP-dependent protein kinase I: Cyclic nucleotide binding, structural changes, and release of the catalytic subunits
1981 StandoutNobel
Understanding Adipocyte Differentiation
1998 Standout
Angiotensin II Receptors in Bovine Adrenal Cortex
1974
Empiric High-Dose 131-Iodine Therapy Lacks Efficacy for Treated Papillary Thyroid Cancer Patients with Detectable Serum Thyroglobulin, but Negative Cervical Sonography and 18F-Fluorodeoxyglucose Positron Emission Tomography Scan
2010
A simple method for displaying the hydropathic character of a protein
1982 Standout
In vitro reconstitution of the human RISC-loading complex
2008 StandoutNobel
Spectroscopic studies of the cAMP binding sites of the regulatory subunits of types I and II protein kinase.
1980
Kinetics of Folding of Staphylococcal Nuclease
1970 StandoutScienceNobel
Anatomy and Dynamics of a Supramolecular Membrane Protein Cluster
2007 StandoutScienceNobel
Isolation of a Mouse Submaxillary Gland Protein Accelerating Incisor Eruption and Eyelid Opening in the New-born Animal
1962 StandoutNobel
Studies on Receptor-mediated Activation of Adenylyl Cyclases
1974
The evolving role of (131)I for the treatment of differentiated thyroid carcinoma.
2005
A protease-resistant protein is a structural component of the Scrapie prion
1983 StandoutNobel
Solid‐Phase Peptide Synthesis
1969 StandoutNobel
A mutation that impairs the ability of lipoprotein receptors to localise in coated pits on the cell surface of human fibroblasts
1977 StandoutNatureNobel
A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation.
2002
Separation and properties of cellular and scrapie prion proteins.
1986 StandoutNobel
Approach to the Patient with a Positive Serum Thyroglobulin and a Negative Radioiodine Scan after Initial Therapy for Differentiated Thyroid Cancer
2008
Binding of Large Organic Anions and Neutral Molecules by Native Bovine Serum Albumin*
1966
Allosteric activation of the CaR by l -amino acids
2000 StandoutNobel
Affinity purification of synthetic peptides.
1976 StandoutNobel
Fmoc-Based Synthesis of Peptide-αThioesters: Application to the Total Chemical Synthesis of a Glycoprotein by Native Chemical Ligation
1999 StandoutNobel
Mechanisms and prevention of trifluoroacetylation in solid-phase peptide synthesis
1979 StandoutNobel
High resolution two-dimensional electrophoresis of proteins.
1975 Standout
Stimulation of Proteinase K Action by Denaturing Agents: Application to the Isolation of Nucleic Acids and the Degradation of ‘Masked’ Proteins
1975
Mutation in LDL Receptor: Alu-Alu Recombination Deletes Exons Encoding Transmembrane and Cytoplasmic Domains
1985 StandoutScienceNobel
External beam radiotherapy with or without concurrent chemotherapy in advanced or recurrent non-anaplastic non-medullary thyroid cancer
2014
A Consensus Report of the Role of Serum Thyroglobulin as a Monitoring Method for Low-Risk Patients with Papillary Thyroid Carcinoma
2003
Side-Chain Cotton Effects of Ribonuclease*
1966
Models for the Specific Adhesion of Cells to Cells
1978 StandoutScience
Efficacy of Dosimetric Versus Empiric Prescribed Activity of 131I for Therapy of Differentiated Thyroid Cancer
2011
The Reliability of Molecular Weight Determinations by Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis
1969 Standout
Circular dichroism and the conformations of membrane proteins. Studies with red blood cell membranes
1971
AVIDIN. 3. THE NATURE OF THE BIOTIN-BINDING SITE
1963
Catecholamine-induced subsensitivity of adenylate cyclase associated with loss of beta-adrenergic receptor binding sites.
1975 StandoutNobel
Ablation of Thyroid Residues with 30 mCi 131I: A Comparison in Thyroid Cancer Patients Prepared with Recombinant Human TSH or Thyroid Hormone Withdrawal
2002
Modulation of cyclic AMP metabolism by S-adenosylhomocysteine and S-3-deazaadenosylhomocysteine in mouse lymphocytes.
1980 StandoutNobel
Agonist-induced increase in apparent β-adrenergic receptor size
1978 StandoutNobel
Role of secretory component, a secreted glycoprotein, in the specific uptake of IgA dimer by epithelial cells.
1979
Risk-Adapted Management of Thyroid Cancer
2008
Complete nucleotide sequence of the AIDS virus, HTLV-III
1985 StandoutNature
A structural change of the plasma membrane induced by oncogenic viruses: quantitative studies with the freeze-fracture technique.
1975 StandoutNobel
Three-dimensional model of purple membrane obtained by electron microscopy
1975 StandoutNatureNobel
Clustering of low-energy conformations near the native structures of small proteins
1998 StandoutNobel
Works of Martin Sonenberg being referenced
Measurement of membrane potentials (ψ) of erythrocytes and white adipocytes by the accumulation of triphenylmethylphosphonium cation
1980
Effect of gossypol on erythrocyte membrane function: specific inhibition of inorganic anion exchange and interaction with band 3.
1985
Cytocidal effect of gossypol on cultured murine erythroleukemia cells is prevented by serum protein.
1984
Mitogenic Response to TGF-β in 3T3-F442A Cells
1995
Radioiodine Ablation of Thyroid Remnants After Preparation with Recombinant Human Thyrotropin
2001
Up-Regulation of Vinculin Expression in 3T3 Preadipose Cells by Growth Hormone*
1991
Expression of Growth Hormone-Independent Adipogenesis by a 3T3 Cell Variant*
1989
Effects of Tumor Necrosis Factor-α on Antimitogenicity and Cell Cycle-related Proteins in MCF-7 Cells
1995
Growth hormone-induced alteration of morphology and tubulin expression in 3T3 preadipose cells
1989
Role of Insulin in Growth Hormone-Stimulated 3T3 Cell Adipogenesis*
1988
Gossypol inhibition of mitosis, cyclin D1 and Rb protein in human mammary cancer cells and cyclin-D1 transfected human fibrosarcoma cells
1997
Resistance of [ 18 F]-Fluorodeoxyglucose-Avid Metastatic Thyroid Cancer Lesions to Treatment with High-Dose Radioactive Iodine
2001
Interaction of Human Growth Hormone and Human Erythrocyte Membranes Studied by Intrinsic Fluorescence
1971
SOLID PHASE SYNTHESIS OF BOVINE PITUITARY GROWTH HORMONE‐(123–131) NONAPEPTIDE
1974 StandoutNobel
LOCALIZATION OF RADIOACTIVITY AFTER ADMINISTRATION OF LABELED PROLACTIN PREPARATIONS TO THE FEMALE RAT
1951
Peptides of a biologically active tryptic digest of bovine growth hormone
1970
Growth hormone and adipose differentiation: growth hormone-induced antimitogenic state in 3T3-F442A preadipose cells.
1990
Hormones modulate adipocyte membrane potential ATP and lipolysis via free fatty acids
1983
The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer.
1962
The effect of altered transmembrane ion gradients on membrane potential and aggregation of human platelets in blood plasma
1981
Interaction of human growth hormone and human erythrocyte membranes as demonstrated by
1969
STUDIES WITH LABELLED ANTERIOR PITUITARY PREPARATIONS: ADRENOCORTICOTROPIN
1951
Interaction of liver plasma membranes and GTP with GTP hydrolysis
1973
1. Peripheral Facial Nerve Palsy After High-Dose Radioiodine Therapy in Patients with Papillary Thyroid Carcinoma
1995
RADIATION PNEUMONITIS AND FIBROSIS: A COMPLICATION OF RADIOIODINE TREATMENT OF PULMONARY METASTASES FROM CANCER OF THE THYROID*
1957
Iodine Kinetics in Man—A Model
1968
Alteration of liver plasma membrane protein conformation by bovine growth hormone in vitro
1973
The Effect of Dodecyl Sulfate on the Ultraviolet Spectra of Proteins*
1962
Modification by bovine growth hormone of liver plasma membrane enzymes, phospholipids, and circular dichroism
1973
Further chemical characterization and biological activities of fluorescent I,N6-ethenoadenosine derivatives
1975
Accumulation of a slowly dissociable peptide hormone binding component by isolated target cells.
1978